Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 21.5M | 18.9M | 23.7M | 25.4M |
Selling general and admin | 4.3M | 4.4M | 6.1M | 7.2M |
Other operating expenses | — | — | — | — |
Operating income | -26.6M | -23.9M | -30.3M | -33.8M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -27.1M | -23.0M | -30.4M | -33.1M |
Tax provision | 0 | 7K | 0 | 0 |
Net income | -27.1M | -23.0M | -30.4M | -33.1M |
Basic EPS | -0.3 | — | -0.3 | -0.3 |
Diluted EPS | -0.3 | — | -0.3 | -0.3 |
Basic average shares | 115.3M | — | 108.1M | 108.1M |
Diluted average shares | 115.3M | — | 108.1M | 108.1M |
EBITDA | -25.0M | -22.8M | -28.6M | -31.4M |
Net income from continuing op. | -27.1M | -23.0M | -30.4M | -33.1M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |